Medical Device | December 08, 2021
Venair showcases its Vena Flexip and Flexpure
The company plans to expand their capacity to meet the needs of pharma and biotech industries
The company plans to expand their capacity to meet the needs of pharma and biotech industries
Sputnik M is a new member of the Sputnik vaccines family
The facility will supply clinical trial materials for the development of vaccines and biologics up to Phase II stage and is expected to be fully operational by early 2023.
Lupin had earlier received the U.S. FDA acceptance of the Biologics License Application (BLA) for Its proposed biosimilar
Fexofinadine is the most widely used, second-generation antihistamine drug for the treatment of allergy symptoms and hay fever
The first hospital in Kharadi launched three years ago has made a significant difference to women and children's health
Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively
She replaces Victoria Tabiner, who is stepping down after 10 years at Sygnature
The country’s top heart transplant surgeon Dr. K.R Balakrishnan to be leading the programme for Jaslok
ALASTIN’s patented, differentiated technology and products are highly synergistic with Galderma’s premium portfolio
Subscribe To Our Newsletter & Stay Updated
